Close
Leave blank for all. Otherwise, the first selected term will be the default instead of "Any".

Pilot Circuit Breaker Proposal: SEC issues proposal on pilot circuit breaker program to combat abusive short selling

Mar 10 2016
BIO commends the SEC on its pilot circuit breaker proposal and urges the use of biotech companies in such proposal

Sarbanes-Oxley in Financial Services Compromise: Sarbanes-Oxley 404(b) Legislative Text in the Wall Street Reform and Consumer Protection Act of 2009

Mar 10 2016
BIO advocated for a provision in financial services reform that would ease regulatory burdens for small public biotechnology companies.

Sarbanes Oxley 404(b) recommendations made by the 2009 Government-Business Forum on Small Business Capital Formation

Mar 10 2016

...

IFRS Roadmap: SEC requests comments on U.S. conversion to a set of global accounting standards

Mar 10 2016
BIO provides comment letter to SEC generally supporting the IFRS roadmap while maintaining safeguards for emerging companies during transition.

Letter to the Honorable John Carey

Mar 10 2016
Letter to the Honorable John Carey, Chairman of the Senate Committee on Finance and Financial Institutions in Ohio from BIO, regarding House Bill 66.

Letter to Governor Deval Patrick

Mar 10 2016
BIO letter to Governor Deval Patrick of Massachusetts regarding concerns about Senate Bill 2863.

BIO Testimony regarding Oregan Senate Bill 570

Mar 10 2016
Testimony to the Oregon Senate Environment & Land Use Committee regarding The Oregon Genetically Engineered Pharmaceutical and Industrial Crop Act.

Questions for the District of Columbia Board of Pharmacy for the drafting of SafeRx

Mar 10 2016
Frequently Asked Questions Document

Clinical Trials: ICTRP guidelines

Mar 10 2016
BIO urges the ICTRP to focus on developing a procedure that would address the need to balance the incentive to innovate with the need to provide patients and health care providers with the information they need in order to assess the availability and suitability of a clinical trial.

Clinical Trials: Review of the Declaration of Helsinki

Mar 10 2016
BIO’s comments on the World Medical Association’s (WMA’s) Declaration of Helsinki.